Mirum Pharmaceuticals, Inc.
MIRM
$72.73
$0.921.28%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -58.56M | -77.34M | -87.94M | -99.81M | -109.16M |
| Total Depreciation and Amortization | 25.57M | 25.37M | 24.98M | 23.69M | 20.29M |
| Total Amortization of Deferred Charges | 1.70M | 1.68M | 1.66M | 1.64M | 1.63M |
| Total Other Non-Cash Items | 56.49M | 51.52M | 44.47M | 51.86M | 51.39M |
| Change in Net Operating Assets | -16.20M | -8.08M | 27.16M | 21.39M | 12.42M |
| Cash from Operations | 9.00M | -6.85M | 10.33M | -1.23M | -23.43M |
| Capital Expenditure | -368.00K | -1.02M | -993.00K | -973.00K | -792.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | -212.76M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -39.76M | -105.23M | -89.13M | -91.79M | -43.94M |
| Cash from Investing | -40.13M | -106.25M | -90.13M | -92.77M | -257.49M |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 24.25M | 22.85M | 17.70M | 14.42M | 217.68M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -281.00K | -281.00K |
| Cash from Financing | 24.25M | 22.85M | 17.70M | 14.14M | 217.40M |
| Foreign Exchange rate Adjustments | 1.99M | -355.00K | -1.30M | 190.00K | -213.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.89M | -90.60M | -63.40M | -79.67M | -63.73M |